Hepatitis A Virus Infection in Cynomolgus Monkeys Confounds the Safety Evaluation of a Drug Candidate
International Journal of Toxicology · 2024
DOI: 10.1177/10915818241237992 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Toxicology, 2024. Verfasst von Chris J Powell und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRC Toxicology Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Macaca fascicularis, Liver, Hepatitis A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In a 3-month toxicity study in cynomolgus monkeys at a European contract laboratory, animals were infected with HAV, initially resulting in hepatic injury being incorrectly attributed to the test compound. Elevated serum ALT/AST/GLDH (5- to 10-fold) were noted in individual animals from all groups including controls, with no apparent dose, exposure, or time-related relationship. Liver histopathology revealed minimal to slight inflammatory cell accumulation in periportal zones of most animals, and minimal to slight hepatocyte degeneration/necrosis in 10/42 animals from all groups. As these findings were more pronounced in 6 drug-treated animals, including 2/6 in the low dose group, the draft report concluded: “ treatment-related hepatotoxicity at all dose levels precluded determination of a NOAEL .” However, the unusual pattern of hepatotoxicity suggested a factor other than drug exposure might have caused the hepatic effects. Therefore, snap-frozen liver samples were tested for hepatitis viruses using a PCR method. Tests for hepatitis B, C, and E virus were negative; however, 20/42 samples were positive for hepatitis A virus (HAV). Infection was strongly associated with increased serum ALT/GLDH, and/or hepatocyte degeneration/necrosis. Re-evaluation of the study in light of these data concluded that the hepatic injury was not drug-related. A subsequent 6-month toxicology study in HAV-vaccinated cynomolgus monkeys confirmed the absence of hepatotoxicity. Identification of HAV infection supported progression of the drug candidate into later clinical trials. Although rarely investigated, subclinical HAV infection has occasionally been reported in laboratory primates, including those used for toxicology studies and it may be more prevalent than the literature indicates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC Toxicology Unit, University of Cambridge, Cambridge, UK.
- Preclinical Safety Associates, LLC, The Woodlands, TX, USA.
- CORES Veterinary Consulting, Walnut Grove, TX, USA.
- ToxPath Sciences Ltd, Congleton, UK.
ORCID-Profile: Chris J Powell
Zitieren
APA
Powell, C. J., Kapeghian, J. C., Bernal, J. C., & Foster, J. R. (2024). Hepatitis A Virus Infection in Cynomolgus Monkeys Confounds the Safety Evaluation of a Drug Candidate. International Journal of Toxicology. https://doi.org/10.1177/10915818241237992
Vancouver
Powell CJ, Kapeghian JC, Bernal JC, Foster JR. Hepatitis A Virus Infection in Cynomolgus Monkeys Confounds the Safety Evaluation of a Drug Candidate. International Journal of Toxicology. 2024. doi:10.1177/10915818241237992
BibTeX
@article{Powell2024,
author = {Powell, Chris J and Kapeghian, John C and Bernal, John C and Foster, John R},
title = {Hepatitis A Virus Infection in Cynomolgus Monkeys Confounds the Safety Evaluation of a Drug Candidate},
journal = {International Journal of Toxicology},
year = {2024},
doi = {10.1177/10915818241237992}
}
EUVIMED